logo
Overview
Discover
Watchlists
Portfolios
Heatmap
Sectors
Trendscore
Performers
Alerts
Options
Earnings
Screeners
Scanners
Backtests
Strategies
Comparisons
Charts
Sign in
Discover

KNSA
Kiniksa Pharmaceuticals International, plc
62.88
2 x 45.37
2 x 80.24
bid
ask
-
1.07
1.67%
2 @ 04:00 PM
59.20 -3.68 (5.86%)
Ytd52.45%
1y130.86%
62.60
day range
64.09
26.27
52 week range
64.81
Open63.64Prev Close63.95Low62.60High64.09Mkt Cap4.84B
Vol657.01KAvg Vol804.98KEPS0.91P/E69.10Forward P/E35.78
Beta0.12Short Ratio5.52Inst. Own102.58%DividendN/ADiv YieldN/A
Ex Div DateN/AEarning07-2850-d Avg53.39200-d Avg44.931yr Est65.13

KNSA News

What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now?
zacks.com
What Makes Kiniksa Pharmaceuticals International, plc (KNSA) a Strong Momentum Stock: Buy Now?

Does Kiniksa Pharmaceuticals International, plc (KNSA) have what it takes to be a top stock pick for

Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gains?
zacks.com
Kiniksa Pharmaceuticals International, plc (KNSA) Surges 5.4%: Is This an Indication of Further Gain

Kiniksa Pharmaceuticals International, plc (KNSA) was a big mover last session on higher-than-averag

benzinga.com
Wedbush Maintains Outperform on Kiniksa Pharmaceuticals, Raises Price Target to $72

Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Outperf

Grab These 4 Stocks With Solid Net Profit Margins to Maximize Returns
zacks.com
Grab These 4 Stocks With Solid Net Profit Margins to Maximize Returns

Let's take a look at four stocks, BTSG, KNSA, ATI and VMI, with stellar net profit margins and risin

Here's Why You Should Add Kiniksa Stock to Your Portfolio Now
zacks.com
Here's Why You Should Add Kiniksa Stock to Your Portfolio Now

KNSA's Arcalyst sales continue to grow as raised 2026 revenue guidance and an expanding IL-1 pipelin